DK1000063T3 - 4-oxo-3,5-dihydro-4H-pyridazin[4,5-b]indol-1-acetamidderivater, fremstilling heraf og terapeutisk anvendelse heraf - Google Patents

4-oxo-3,5-dihydro-4H-pyridazin[4,5-b]indol-1-acetamidderivater, fremstilling heraf og terapeutisk anvendelse heraf

Info

Publication number
DK1000063T3
DK1000063T3 DK98941468T DK98941468T DK1000063T3 DK 1000063 T3 DK1000063 T3 DK 1000063T3 DK 98941468 T DK98941468 T DK 98941468T DK 98941468 T DK98941468 T DK 98941468T DK 1000063 T3 DK1000063 T3 DK 1000063T3
Authority
DK
Denmark
Prior art keywords
pyridazine
indole
dihydro
oxo
preparation
Prior art date
Application number
DK98941468T
Other languages
Danish (da)
English (en)
Inventor
Yannick Evanno
Laurent Dubois
Mireille Sevrin
Frank Marguet
Jacques Froissant
Regine Bartsch
Catherine Gille
Original Assignee
Sanofi Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo filed Critical Sanofi Synthelabo
Application granted granted Critical
Publication of DK1000063T3 publication Critical patent/DK1000063T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A61P25/12—Antiepileptics; Anticonvulsants for grand-mal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Addiction (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DK98941468T 1997-07-30 1998-07-28 4-oxo-3,5-dihydro-4H-pyridazin[4,5-b]indol-1-acetamidderivater, fremstilling heraf og terapeutisk anvendelse heraf DK1000063T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9709692A FR2766823B1 (fr) 1997-07-30 1997-07-30 Derives de 4-oxo-3,5-dihydro-4h-pyridazino[4,5-b] indole-1-acetamide, leur preparation et leur application en therapeutique
PCT/FR1998/001667 WO1999006406A1 (fr) 1997-07-30 1998-07-28 DERIVES DE 4-OXO-3,5-DIHYDRO-4H-PYRIDAZINO[4,5-b] INDOLE-1-ACETAMIDE, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE

Publications (1)

Publication Number Publication Date
DK1000063T3 true DK1000063T3 (da) 2003-02-24

Family

ID=9509801

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98941468T DK1000063T3 (da) 1997-07-30 1998-07-28 4-oxo-3,5-dihydro-4H-pyridazin[4,5-b]indol-1-acetamidderivater, fremstilling heraf og terapeutisk anvendelse heraf

Country Status (33)

Country Link
US (1) US6262045B1 (ko)
EP (1) EP1000063B1 (ko)
JP (1) JP4322421B2 (ko)
KR (1) KR100497782B1 (ko)
CN (1) CN1134440C (ko)
AR (1) AR013264A1 (ko)
AT (1) ATE226584T1 (ko)
AU (1) AU736600B2 (ko)
BG (1) BG64283B1 (ko)
BR (1) BR9811582B1 (ko)
CA (1) CA2298522C (ko)
CO (1) CO5210883A1 (ko)
CZ (1) CZ290011B6 (ko)
DE (1) DE69808921T2 (ko)
DK (1) DK1000063T3 (ko)
EE (1) EE04317B1 (ko)
ES (1) ES2186212T3 (ko)
FR (1) FR2766823B1 (ko)
HK (1) HK1028027A1 (ko)
HU (1) HU229430B1 (ko)
IL (1) IL133633A (ko)
NO (1) NO313963B1 (ko)
NZ (1) NZ502361A (ko)
PL (1) PL194245B1 (ko)
PT (1) PT1000063E (ko)
RU (1) RU2197490C2 (ko)
SI (1) SI1000063T1 (ko)
SK (1) SK283075B6 (ko)
TR (1) TR200000278T2 (ko)
TW (1) TW506971B (ko)
UA (1) UA57088C2 (ko)
WO (1) WO1999006406A1 (ko)
ZA (1) ZA986786B (ko)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2788696B1 (fr) * 1999-01-26 2004-03-05 Synthelabo Utilisation de derives de pyridazino [4,5-b] indole-1-acetamide pour la preparation de medicaments destines aux maladies du systeme nerveux central
FR2788776B1 (fr) 1999-01-26 2001-02-23 Synthelabo Derives de 4-oxo-3, 5-dihydro-4h-pyridazino [4,5-b] indole-1 -carboxamide, leur preparation et leur application en therapeutique
GB0000564D0 (en) 2000-01-11 2000-03-01 Merck Sharp & Dohme Therapeutic agents
FR2811897A1 (fr) * 2000-07-24 2002-01-25 Sanofi Synthelabo UTILISATION DE DERIVES DE PYRIDAZINO[4,5-b]INDOLE-1- ACETAMIDE POUR LA PREPARATION DE MEDICAMENTS DESTINES AU TRAITEMENT DES DYSFONCTIONNEMENTS DES RECEPTEURS DE TYPE PERIPHERIQUE AUX BENZODIAZEPINES
FR2811990A1 (fr) * 2000-07-24 2002-01-25 Sanofi Synthelabo DERIVES DE 1-(4-OXO-3,5-DIHYDRO-4H-PYRIDAZINO[4,5-b]INDOLE-1 -CARBONYL)PIPERAZINE, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE
FR2833953B1 (fr) * 2001-12-21 2004-12-03 Sanofi Synthelabo DERIVES DE 3-HETEROARYL-3,5-DIHYDRO-4-OXO-4H-PYRIDAZINO [4,5-b]INDOLE-1-CARBOXAMIDE, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE
FR2838124B1 (fr) 2002-04-03 2004-05-28 Sanofi Synthelabo Derives de 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino [4,5-b]indole-1-acetamide, leur preparation et leur application en therapeutique
JP5483874B2 (ja) * 2005-05-05 2014-05-07 サノフィ−アベンティス・ユー・エス・エルエルシー 安定なナノ粒子処方物
NZ566313A (en) * 2005-08-29 2011-04-29 Sanofi Aventis Us Llc Amorphous solid dispersions of 7-chloro-N,N,5-trimethyl-4-oxo-3-phenyl-3,5-dihydro-4H-pyridazino[4, 5-b]indole-1-acetamide
PT1924585E (pt) * 2005-08-29 2012-01-19 Sanofi Aventis Us Llc Nova forma cristalina de um derivado de piridazino[4,5-b]indole
MX2008004024A (es) * 2005-09-23 2009-02-27 Schering Corp Antagonistas de receptor de glutamato metabotropico-1 tetraciclicos fusionados como agentes terapeuticos.
CN1946120B (zh) * 2006-10-20 2010-05-12 华为技术有限公司 实现话单关联的方法及系统
AU2009283039A1 (en) * 2008-08-18 2010-02-25 Sanofi-Aventis U.S. Llc Process for preparing polymorph of 7-chloro-N, N,5-trimethyl-4-oxo-3-phenyl-3,5-dihydr0-4H-pyridazin0[4,5-b]indole-1-acetamide
EP2181717A1 (en) 2008-10-28 2010-05-05 Sanofi-Aventis Use of 7-chloro-N,N,5-trimethyl-4-oxo-3-phenyl-3,5-dihydro-4H-pyridazino[4,5-B]indole-1-acetamide as a biomarker of peripheral benzodiazepine receptor levels

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4985560A (en) * 1990-01-12 1991-01-15 American Home Products Corporation Pyridazino(4,5-b)indolizines
GB9411955D0 (en) * 1994-06-15 1994-08-03 Merck Sharp & Dohme Therapeutic agents
US5756501A (en) * 1995-12-13 1998-05-26 American Home Products Corporation Saturated and unsaturated pyridazino 4,5-B! indolizines useful as antidementia agents
FR2754262B1 (fr) 1996-10-08 1998-10-30 Synthelabo Derives de 1h-pyrido[3,4-b]indole-4-carboxamide, leur preparation et leur application en therapeutique

Also Published As

Publication number Publication date
JP2001512122A (ja) 2001-08-21
BR9811582B1 (pt) 2010-10-19
EE04317B1 (et) 2004-06-15
TR200000278T2 (tr) 2000-08-21
KR100497782B1 (ko) 2005-06-27
SK1292000A3 (en) 2000-08-14
CA2298522C (en) 2008-07-15
NZ502361A (en) 2001-06-29
PL194245B1 (pl) 2007-05-31
NO20000462D0 (no) 2000-01-28
SI1000063T1 (en) 2003-04-30
IL133633A (en) 2004-02-08
HUP0002650A2 (hu) 2001-01-29
US6262045B1 (en) 2001-07-17
ES2186212T3 (es) 2003-05-01
TW506971B (en) 2002-10-21
ZA986786B (en) 1999-02-02
CA2298522A1 (en) 1999-02-11
HK1028027A1 (en) 2001-02-02
ATE226584T1 (de) 2002-11-15
AR013264A1 (es) 2000-12-13
CN1134440C (zh) 2004-01-14
UA57088C2 (uk) 2003-06-16
SK283075B6 (sk) 2003-02-04
AU8983298A (en) 1999-02-22
CO5210883A1 (es) 2002-10-30
CZ2000320A3 (cs) 2000-05-17
JP4322421B2 (ja) 2009-09-02
DE69808921D1 (de) 2002-11-28
NO313963B1 (no) 2003-01-06
BR9811582A (pt) 2000-09-26
BG104096A (en) 2000-08-31
HU229430B1 (en) 2013-12-30
WO1999006406A1 (fr) 1999-02-11
FR2766823A1 (fr) 1999-02-05
EP1000063B1 (fr) 2002-10-23
AU736600B2 (en) 2001-08-02
KR20010022356A (ko) 2001-03-15
EP1000063A1 (fr) 2000-05-17
FR2766823B1 (fr) 1999-10-08
CZ290011B6 (cs) 2002-05-15
HUP0002650A3 (en) 2002-09-30
PT1000063E (pt) 2003-03-31
DE69808921T2 (de) 2003-07-03
BG64283B1 (bg) 2004-08-31
IL133633A0 (en) 2001-04-30
RU2197490C2 (ru) 2003-01-27
NO20000462L (no) 2000-03-29
PL338445A1 (en) 2000-11-06
CN1265108A (zh) 2000-08-30
EE200000056A (et) 2000-10-16

Similar Documents

Publication Publication Date Title
NZ330092A (en) Dithiolan derivatives, their preparation and their therapeutic effect
EE9800459A (et) Spiro-piperidiini derivaadid ja nende kasutamine terapeutiliste toimeainetena
EE05000B1 (et) 2'-asendatud 1,1'-bifenüül-2-karboksamiidid, nende kasutamine ja farmatseutilised preparaadid
EE200100470A (et) Püridopüranoasepiini derivaadid, nende valmistamine ja terapeutiline kasutamine
NO943682D0 (no) Imidazol-4-yl-piperidin-derivater, deres fremstilling og terapeutiske anvendelse
ZA989556B (en) Benzoxazine derivatives their preparation and their therapeutic application
DK1000063T3 (da) 4-oxo-3,5-dihydro-4H-pyridazin[4,5-b]indol-1-acetamidderivater, fremstilling heraf og terapeutisk anvendelse heraf
NO991624D0 (no) 1H-pyrido[3,4-b]indol-4-karboksamid-derivater, fremstilling og anvendelse derav i terapeutiske midler
FI956298A0 (fi) 3-fenyyli-isokinolin-1(2H)-oneja, niiden valmistus ja terapeuttinen käyttö
NO992676D0 (no) 1,4-diazabicyklo[2,2,2]okt-2-ylmetylderivater, deres fremstilling og terapeutiske anvendelse
DK1025100T3 (da) 3-substituerede tetrahydropyridopyrimidinonderivater, fremstilling og anvendelsen heraf
DE60002043D1 (de) 4-oxo-3,5-dihydro-4h-pyridazino[4,5-b]indol-1-carboxamid-derivate, ihre herstellung und therapeutische verwendung
EE9800333A (et) Uued furaandiarüülmetülideeni derivaadid, nende valmistamise meetod ja kasutamine teraapias
EE9900414A (et) 2,3-dihüdrofuro[3,2-b]püridiini derivaadid, nende valmistamine ja kasutamine raviks
EE200000207A (et) 8-asabitsüklo[3.2.1]oktaan-3-metaanamiini derivaadid, nende valmistamine ja terapeutiline kasutamine
EE200000018A (et) 6-pürrolidiin-2-üülpüridiinid, nende valmistamine ja terapeutiline kasutamine
NO982549D0 (no) 5-naftalen-1-yl-1,3-dioksan-derivater, fremstilling og terapeutisk anvendelse derav
PL371201A1 (en) 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino[4,5-b]indole-1-carboxamide derivatives, their preparation and therapeutic use
FR2769914B1 (fr) Derives d'indazole tricycliques leur preparation et leur application en therapeutique
IL149653A0 (en) 2-arylquinoline derivatives, preparation and therapeutic use thereof
ZA964518B (en) Benzimidazole derivatives their preparation and their therapeutic use
DK0906297T3 (da) 1,2,4-Benzothiadiazinderivater, fremstilling og anvendelse deraf